S&P 500   3,852.36
DOW   32,920.46
QQQ   311.72
Retirement Plans in 2023: Choosing the Right Account
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Mullen Automotive Stock Gains Momentum On Positive News
Apple’s Earnings, Expectations and Surprises
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Cathie Woods' Ark Innovation ETF Set To Rebound in 2023?
The Bottom Is In For Meta Platforms, Volatility Is Not Over
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Exxon Mobil Could Gush To New Highs Very Soon 
Closing prices for crude oil, gold and other commodities
S&P 500   3,852.36
DOW   32,920.46
QQQ   311.72
Retirement Plans in 2023: Choosing the Right Account
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Mullen Automotive Stock Gains Momentum On Positive News
Apple’s Earnings, Expectations and Surprises
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Cathie Woods' Ark Innovation ETF Set To Rebound in 2023?
The Bottom Is In For Meta Platforms, Volatility Is Not Over
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Exxon Mobil Could Gush To New Highs Very Soon 
Closing prices for crude oil, gold and other commodities
S&P 500   3,852.36
DOW   32,920.46
QQQ   311.72
Retirement Plans in 2023: Choosing the Right Account
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Mullen Automotive Stock Gains Momentum On Positive News
Apple’s Earnings, Expectations and Surprises
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Cathie Woods' Ark Innovation ETF Set To Rebound in 2023?
The Bottom Is In For Meta Platforms, Volatility Is Not Over
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Exxon Mobil Could Gush To New Highs Very Soon 
Closing prices for crude oil, gold and other commodities
S&P 500   3,852.36
DOW   32,920.46
QQQ   311.72
Retirement Plans in 2023: Choosing the Right Account
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Mullen Automotive Stock Gains Momentum On Positive News
Apple’s Earnings, Expectations and Surprises
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Cathie Woods' Ark Innovation ETF Set To Rebound in 2023?
The Bottom Is In For Meta Platforms, Volatility Is Not Over
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Exxon Mobil Could Gush To New Highs Very Soon 
Closing prices for crude oil, gold and other commodities
NASDAQ:AHCO

AdaptHealth - AHCO Stock Forecast, Price & News

$21.33
-0.05 (-0.23%)
(As of 02/2/2023 12:00 AM ET)
Add
Compare
Today's Range
$21.12
$21.90
50-Day Range
$19.02
$22.86
52-Week Range
$11.40
$27.48
Volume
842,708 shs
Average Volume
622,378 shs
Market Capitalization
$2.87 billion
P/E Ratio
49.60
Dividend Yield
N/A
Price Target
$27.67

AdaptHealth MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
29.7% Upside
$27.67 Price Target
Short Interest
Bearish
13.98% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.57mentions of AdaptHealth in the last 14 days
Based on 2 Articles This Week
Insider Trading
Selling Shares
$15.66 M Sold Last Quarter
Proj. Earnings Growth
51.76%
From $0.85 to $1.29 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.84 out of 5 stars

Medical Sector

33rd out of 1,030 stocks

Home Health Care Services Industry

3rd out of 9 stocks

AHCO stock logo

About AdaptHealth (NASDAQ:AHCO) Stock

AdaptHealth Corp. engages in the provision of home healthcare equipment, supplies and related services. It focuses on sleep therapy equipment to individuals suffering from obstructive sleep apnea (OSA), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and HME medical devices and supplies on behalf of chronically ill patients with diabetes care, wound care, urological, ostomy, and nutritional supply needs. The company was founded in 2012 and is headquartered in Plymouth Meeting, PA.

Receive AHCO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AdaptHealth and its competitors with MarketBeat's FREE daily newsletter.

AHCO Stock News Headlines

Know Your Profit Potential BEFORE You Trade!
I’m Chuck Hughes, ten-time trading champion and author of the coveted e-book, “Options Trading Made Easy”, the strategy guide that will teach you to calculate your trade’s profit potential before you risk any capital. Click here for a free copy now! pixel
Know Your Profit Potential BEFORE You Trade!
I’m Chuck Hughes, ten-time trading champion and author of the coveted e-book, “Options Trading Made Easy”, the strategy guide that will teach you to calculate your trade’s profit potential before you risk any capital. Click here for a free copy now! pixel
4 Analysts Have This to Say About AdaptHealth
Where AdaptHealth Stands With Analysts
See More Headlines
Receive AHCO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AdaptHealth and its competitors with MarketBeat's FREE daily newsletter.

AHCO Company Calendar

Last Earnings
11/08/2022
Today
2/03/2023
Next Earnings (Confirmed)
2/28/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Home health care services
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:AHCO
Fax
N/A
Employees
10,700
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$27.67
High Stock Price Forecast
$30.00
Low Stock Price Forecast
$26.00
Forecasted Upside/Downside
+29.7%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
5 Analysts

Profitability

Net Income
$156.18 million
Pretax Margin
4.43%

Debt

Sales & Book Value

Annual Sales
$2.45 billion
Cash Flow
$3.12 per share
Book Value
$15.44 per share

Miscellaneous

Free Float
111,423,000
Market Cap
$2.87 billion
Optionable
Not Optionable
Beta
0.65

Key Executives

  • Stephen P. GriggsStephen P. Griggs
    Chief Executive Officer & Director
  • Joshua Parnes
    President & Director
  • Jason A. ClemensJason A. Clemens
    Chief Financial & Accounting Officer
  • Albert A. Prast
    Chief Technology Officer
  • Wendy Russalesi
    Chief Compliance Officer













AHCO Stock - Frequently Asked Questions

Should I buy or sell AdaptHealth stock right now?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AdaptHealth in the last year. There are currently 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" AHCO shares.
View AHCO analyst ratings
or view top-rated stocks.

What is AdaptHealth's stock price forecast for 2023?

5 equities research analysts have issued 1 year target prices for AdaptHealth's stock. Their AHCO share price forecasts range from $26.00 to $30.00. On average, they anticipate the company's share price to reach $27.67 in the next year. This suggests a possible upside of 29.7% from the stock's current price.
View analysts price targets for AHCO
or view top-rated stocks among Wall Street analysts.

How have AHCO shares performed in 2023?

AdaptHealth's stock was trading at $19.22 on January 1st, 2023. Since then, AHCO shares have increased by 11.0% and is now trading at $21.33.
View the best growth stocks for 2023 here
.

When is AdaptHealth's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 28th 2023.
View our AHCO earnings forecast
.

How were AdaptHealth's earnings last quarter?

AdaptHealth Corp. (NASDAQ:AHCO) released its quarterly earnings results on Tuesday, November, 8th. The company reported $0.11 EPS for the quarter, missing the consensus estimate of $0.31 by $0.20. The firm had revenue of $756.50 million for the quarter, compared to analysts' expectations of $738.58 million. AdaptHealth had a net margin of 3.28% and a trailing twelve-month return on equity of 4.38%.

What guidance has AdaptHealth issued on next quarter's earnings?

AdaptHealth issued an update on its FY 2022 earnings guidance on Friday, January, 27th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $2.98 billion-$2.98 billion, compared to the consensus revenue estimate of $2.98 billion.

What other stocks do shareholders of AdaptHealth own?
What is AdaptHealth's stock symbol?

AdaptHealth trades on the NASDAQ under the ticker symbol "AHCO."

Who are AdaptHealth's major shareholders?

AdaptHealth's stock is owned by a variety of retail and institutional investors. Top institutional investors include Sumitomo Mitsui Trust Holdings Inc. (2.21%), Reinhart Partners Inc. (0.37%), LGT Capital Partners LTD. (0.32%), Scout Investments Inc. (0.31%), New York State Common Retirement Fund (0.27%) and New York State Teachers Retirement System (0.06%). Insiders that own company stock include Aero Holdings Ii Ll Skyknight, Alan G Quasha, Assured Investment Management, Christopher J Joyce, Dale B Wolf, Daniel Bunting, Everest Hill Group Inc, Frank Mullen, Jason A Clemens, Ronald T Mcdaniel, Shaw Rietkerk, Skyknight Capital Fund Ii, LP and Stephen P Griggs.
View institutional ownership trends
.

How do I buy shares of AdaptHealth?

Shares of AHCO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is AdaptHealth's stock price today?

One share of AHCO stock can currently be purchased for approximately $21.33.

How much money does AdaptHealth make?

AdaptHealth (NASDAQ:AHCO) has a market capitalization of $2.87 billion and generates $2.45 billion in revenue each year. The company earns $156.18 million in net income (profit) each year or $0.43 on an earnings per share basis.

How many employees does AdaptHealth have?

The company employs 10,700 workers across the globe.

How can I contact AdaptHealth?

AdaptHealth's mailing address is 220 West Germantown Pike Suite 250, Plymouth Meeting PA, 19462. The official website for the company is www.adapthealth.com. The company can be reached via phone at (610) 424-4515 or via email at dsullivan@equityny.com.

This page (NASDAQ:AHCO) was last updated on 2/3/2023 by MarketBeat.com Staff